X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
thiazoles - pharmacology (11841) 11841
animals (10495) 10495
humans (9647) 9647
male (5370) 5370
pharmacology & pharmacy (4434) 4434
rats (4433) 4433
mice (3964) 3964
thiazoles (3260) 3260
female (3186) 3186
thiazoles - chemistry (2921) 2921
chemistry, medicinal (2603) 2603
dose-response relationship, drug (2584) 2584
biochemistry & molecular biology (2342) 2342
tetrazolium salts (2257) 2257
thiazoles - therapeutic use (2124) 2124
cell line, tumor (2103) 2103
thiazoles - chemical synthesis (2087) 2087
structure-activity relationship (1981) 1981
cells, cultured (1757) 1757
apoptosis (1593) 1593
antineoplastic agents - pharmacology (1535) 1535
cell survival - drug effects (1516) 1516
thiazolidinediones (1455) 1455
thiazoles - metabolism (1451) 1451
time factors (1427) 1427
cell line (1345) 1345
expression (1323) 1323
neurosciences (1287) 1287
thiazoles - administration & dosage (1274) 1274
oncology (1236) 1236
in-vitro (1235) 1235
adult (1211) 1211
molecular structure (1202) 1202
analysis (1196) 1196
apoptosis - drug effects (1169) 1169
rats, sprague-dawley (1152) 1152
cancer (1061) 1061
enzyme inhibitors - pharmacology (1036) 1036
in vitro techniques (1024) 1024
cell biology (1020) 1020
thiazolidines (1007) 1007
middle aged (1005) 1005
cell proliferation - drug effects (1004) 1004
thiazoles - pharmacokinetics (977) 977
blotting, western (926) 926
cells (865) 865
kinetics (863) 863
activation (844) 844
pyrimidines - pharmacology (840) 840
rats, wistar (833) 833
research (831) 831
chemistry, organic (827) 827
thiazoles - adverse effects (825) 825
hypoglycemic agents - pharmacology (805) 805
inhibition (800) 800
benzothiazoles (794) 794
toxicology (793) 793
chemistry, multidisciplinary (791) 791
tetrazolium salts - pharmacology (763) 763
derivatives (746) 746
microbial sensitivity tests (727) 727
cytotoxicity (712) 712
phosphorylation (707) 707
tumor cells, cultured (706) 706
pyridines - pharmacology (704) 704
proteins (688) 688
models, molecular (677) 677
coloring agents (667) 667
administration, oral (645) 645
dasatinib (644) 644
oxidative stress (643) 643
growth (634) 634
thiazole (627) 627
inhibitors (622) 622
ligands (619) 619
aged (616) 616
flow cytometry (613) 613
disease models, animal (603) 603
chromans - pharmacology (595) 595
mice, inbred c57bl (585) 585
drug screening assays, antitumor (581) 581
anti-bacterial agents - pharmacology (575) 575
protein kinase inhibitors - pharmacology (573) 573
magnetic resonance spectroscopy (571) 571
endocrinology & metabolism (562) 562
drug interactions (560) 560
signal transduction - drug effects (556) 556
chemistry (553) 553
reverse transcriptase polymerase chain reaction (550) 550
drug design (542) 542
mutation (538) 538
protein binding (534) 534
metabolism (532) 532
troglitazone (528) 528
research article (526) 526
microbiology (525) 525
antineoplastic agents - chemical synthesis (521) 521
dogs (519) 519
toxicity (518) 518
cell division - drug effects (515) 515
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19409) 19409
Japanese (584) 584
German (202) 202
Russian (130) 130
French (128) 128
Ukrainian (90) 90
Chinese (86) 86
Italian (84) 84
Polish (36) 36
Spanish (21) 21
Czech (12) 12
Hungarian (7) 7
Romanian (7) 7
Dutch (5) 5
Slovak (5) 5
Portuguese (3) 3
Danish (1) 1
Finnish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2013, Volume 332, Issue 2, pp. 295 - 303
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 22, pp. 1665 - 1675
Recent advances in tumor biology have made remarkable achievements in the development of therapy for metastatic castrate-resistant prostate cancer. These... 
GROWTH-FACTOR RECEPTOR | CONTROLLED-TRIAL | ANTIANGIOGENIC THERAPY | ONCOLOGY | RANDOMIZED PHASE-II | BONE METASTASES | C-MET | SIPULEUCEL-T APC8015 | ABIRATERONE ACETATE | TUMOR MICROENVIRONMENT | ANGIOGENESIS INHIBITION | Cancer Vaccines - pharmacology | Humans | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Prostatic Neoplasms - immunology | RANK Ligand - pharmacology | Receptors, Androgen - drug effects | Treatment Failure | Prostatic Neoplasms - drug therapy | Phenylthiohydantoin - pharmacology | Tumor Microenvironment - drug effects | Dasatinib | Antibodies, Monoclonal - pharmacology | Angiogenesis Inhibitors - pharmacology | Clusterin - pharmacology | Pyrimidines - pharmacology | Denosumab | Prostate-Specific Antigen - blood | Orchiectomy | Signal Transduction - drug effects | Anilides - pharmacology | Mice | Receptor Cross-Talk - drug effects | Endothelin-1 - antagonists & inhibitors | Immunotherapy - methods | Taxoids - pharmacology | Ipilimumab | Tissue Extracts - pharmacology | Bone Remodeling - drug effects | Pyrrolidines - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Androstenols - pharmacology | Androstenes | Clinical Trials as Topic | Mice, SCID | Phenylthiohydantoin - analogs & derivatives | Biomarkers, Tumor - blood | Xenograft Model Antitumor Assays | Cancer Vaccines - immunology | Pyrroles - pharmacology | Animals | RANK Ligand - antagonists & inhibitors | Pyridines - pharmacology | Thiazoles - pharmacology | Immune response | Development and progression | Cellular signal transduction | Research | Drug therapy | Health aspects | Prostate cancer | Risk factors | Review
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 2012, Volume 20, Issue 11, pp. 3378 - 3395
Journal Article
Journal Article
Journal Article
Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 08/2003, Volume 93, Issue 4, pp. 311 - 320
ABSTRACT—Homocysteine (Hcy) is an independent risk factor for cardiovascular disease. Monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) are... 
Monocyte chemoattractant protein-1 | Monocytes | Homocysteine | Interleukin-8 | Atherosclerosis | homocysteine | atherosclerosis | monocytes | ENDOTHELIAL-CELL INJURY | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | OXIDANT STRESS | monocyte chemoattractant protein-1 | RISK FACTOR | PLASMA HOMOCYST(E)INE | interleukin-8 | VASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | ATHEROMATOUS PLAQUES | HEMATOLOGY | NF-KAPPA-B | T-LYMPHOCYTES | Interleukin-8 - genetics | Reactive Oxygen Species - metabolism | Chemokine CCL2 - secretion | Monocytes - cytology | Humans | Dimethyl Sulfoxide - pharmacology | Monocytes - metabolism | RNA, Messenger - metabolism | Pyrrolidines - pharmacology | Dose-Response Relationship, Drug | Thiocarbamates - pharmacology | Chromans - pharmacology | Time Factors | Homocysteine - pharmacology | Indoles - pharmacology | Interleukin-8 - secretion | Flavonoids - pharmacology | RNA, Messenger - drug effects | RNA, Messenger - genetics | Cells, Cultured | Enzyme Inhibitors - pharmacology | Chemokine CCL2 - genetics | Imidazoles - pharmacology | Tyrphostins - pharmacology | Antioxidants - pharmacology | Onium Compounds - pharmacology | Sulfonamides - pharmacology | Naphthalenes - pharmacology | Gene Expression Regulation - drug effects | Monocytes - drug effects | Genistein - pharmacology | Pyridines - pharmacology | Thiazoles - pharmacology | Thiazolidinediones
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 03/2013, Volume 24, Issue 3, pp. 251 - 259
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 383, Issue 2, pp. 309 - 317
Abstract In previous studies we demonstrated that targeting the nuclear exporter protein exportin-1 (CRM1/XPO1) by a selective inhibitor of nuclear export... 
Hematology, Oncology and Palliative Medicine | NHL | XPO1 | Selective inhibitors of nuclear export | SINE | CRM1 | Exportin-1 | SURVIVAL | DRUG-RESISTANCE | MODEL | CANCER | STRATEGIES | ONCOLOGY | LINE | CHOP | PROTEINS | Vincristine - pharmacology | TOR Serine-Threonine Kinases - metabolism | Transcription Factor RelA - antagonists & inhibitors | Apoptosis - drug effects | Humans | Lymphoma, Non-Hodgkin - enzymology | Lymphoma, Non-Hodgkin - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Dexamethasone - pharmacology | Time Factors | Oxadiazoles - pharmacology | Acrylamides - pharmacology | Lymphoma, Non-Hodgkin - drug therapy | Cell Survival - drug effects | Hydrazines - pharmacology | Everolimus - pharmacology | Mice, SCID | Mice, Inbred ICR | Drug Synergism | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Karyopherins - metabolism | Signal Transduction - drug effects | Transcription Factor RelA - metabolism | Tumor Burden - drug effects | Active Transport, Cell Nucleus - drug effects | Cyclophosphamide - pharmacology | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Cell Line, Tumor | Prednisone - pharmacology | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Karyopherins - antagonists & inhibitors | Doxorubicin - pharmacology | Receptors, Cytoplasmic and Nuclear - metabolism | International trade | Cyclophosphamide | Care and treatment | Dexamethasone | Analysis | Lymphomas | Prednisone | Exports | Steroids | Cancer | Drugs
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2014, Volume 289, Issue 30, pp. 21082 - 21097
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2003, Volume 2, Issue 10, pp. 971 - 984
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 12/2005, Volume 280, Issue 52, pp. 42655 - 42668
How genetic and environmental factors interact in Parkinson disease is poorly understood. We have now compared the patterns of vulnerability and rescue of... 
OXIDATIVE DAMAGE | COMPLEX-I | MEMBRANE PERTURBATION | UBIQUITIN-PROTEIN LIGASE | DROSOPHILA MODEL | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE MODEL | C-ELEGANS | DEFICIENT MICE | HUNTINGTONS-DISEASE | TAUROURSODEOXYCHOLIC ACID | Oncogene Proteins - genetics | Cholagogues and Choleretics - pharmacology | Humans | Molecular Sequence Data | Immunoblotting | Pyridazines - pharmacology | Probucol - pharmacology | Taurochenodeoxycholic Acid - pharmacology | Copper - chemistry | Time Factors | Gene Deletion | Rotenone - pharmacology | Neurons - metabolism | alpha-Synuclein - genetics | Paraquat - pharmacology | Transgenes | Disease Models, Animal | Pyrazoles - pharmacology | Amino Acid Sequence | Parkinson Disease - pathology | Caenorhabditis elegans - metabolism | Electron Transport Complex I - antagonists & inhibitors | Gene Library | Animals, Genetically Modified | Iron - chemistry | Polyenes - pharmacology | Gene Expression Regulation | Oxygen Consumption | Intracellular Signaling Peptides and Proteins | Bile Acids and Salts - metabolism | Ions | Mitochondria - metabolism | Antioxidants - pharmacology | Genetic Techniques | Sequence Homology, Amino Acid | Protein Deglycase DJ-1 | Animals | Mutagenesis | Benzoates - pharmacology | Thiazoles - pharmacology | Mutation | 3-Hydroxybutyric Acid - pharmacology | Ubiquitin-Protein Ligases - genetics | Sodium Azide - pharmacology | Apoptosis | RNA, Small Interfering - metabolism | Index Medicus
Journal Article
Journal Article